Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141487 · ClinicalTrials.gov registry record
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
A clinical trial of Urinary Incontinence and Urinary Bladder, Neurogenic, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT05141487 is a study of Urinary Incontinence and Urinary Bladder, Neurogenic that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 16 participants, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05141487, a study of Urinary Incontinence and Urinary Bladder, Neurogenic, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Incontinence associates with military service and post-traumatic stress disorder in both male and female Veterans. Neurogenic detrusor overactivity (NDO) is caused by spinal cord injury or disorder, or peripheral neurodegenerative conditions, and causes urine leakage at low volumes. NDO is disproportionately experienced by Veterans and treatment effectiveness varies greatly between individuals. This project will demonstrate the feasibility of a new type of nerve stimulation-triggered sacral neuromodulation-to treat NDO in Veterans. A wireless bladder sensor will be inserted into the bladder to transmit a feedback signal enabling stimulation from a percutaneous lead. The wireless sensor will also measure NDO symptoms during simulated activities of daily living without catheters. Catheter-free detection of bladder activity will improve the outcomes of neuromodulation evaluations for Veterans with NDO. Future work could use the triggered neuromodulation system to study other methods of nerve stimulation to treat bladder, bowel, or sexual dysfunction.
Conditions Studied
Interventions
- DEVICE UroMonitor
- DEVICE ASCU
Study Locations (1)
Ohio
- Louis Stokes VA Medical Center, Cleveland, OH - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2026-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05141487
The ClinicalTrials.gov registry entry for NCT05141487 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (94% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which UroMonitor is the first listed.
NCT05141487 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05141487 about?
NCT05141487 is a clinical study titled "Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder". Incontinence associates with military service and post-traumatic stress disorder in both male and female Veterans. Neurogenic detrusor overactivity (NDO) is caused by spinal cord injury or disorder, or peripheral neurodegenerative conditions, and causes urine leakage at low volumes. NDO is dispropor...
What is the current status of trial NCT05141487?
This trial is currently recruiting. The enrollment target is 16 participants. The study started on 2022-10-03. Estimated completion is 2026-10-30.
What conditions does trial NCT05141487 study?
This clinical trial studies the following conditions: Urinary Incontinence, Urinary Bladder, Neurogenic.
What interventions are being tested in trial NCT05141487?
The interventions under investigation include: UroMonitor (DEVICE), ASCU (DEVICE).
Who is sponsoring clinical trial NCT05141487?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05141487 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.